pelican-biothermal

Cold chain freight set for shake up in 2020

Increased use of cell and gene therapy will add complexity to the distribution of temperature-controlled pharmceuticals in the coming year, predicts Kevin Lawler, vice president of worldwide sales at specialist packaging firm, Pelican BioThermal. These therapies are extremely sensitive to temperature fluctuation during transit and pharmaceutical manufacturers will demand increased confidence that these costly therapies will arrive on time, intact, and in temp, to their destinations. He says: “A decade ago, costly ... [+]